Results 141 to 150 of about 2,418,727 (174)
Association between CA-125 and post-extubation respiratory failure: a cohort study. [PDF]
Lombuli F, Montes THM, Boniatti MM.
europepmc +1 more source
Estimating the ovarian cancer CA-125 preclinical detectable phase, in-vivo tumour doubling time, and window for detection in early stage: an exploratory analysis of UKCTOCS. [PDF]
Bedia JS +14 more
europepmc +1 more source
The Potential Role of CA-125 as a Biomarker for Short-Term Mortality Risk in Patients with Acute Symptomatic Pulmonary Embolism. [PDF]
Oblitas CM +8 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
BMJ Case Reports, 2021
We present two unusual presentations of extrapulmonary tuberculosis (EPTB) and more specifically intra-abdominal tuberculosis (TB). These cases were initially suspicious for ovarian cancer, presenting with non-specific symptoms, ultrasound-confirmed ascites and elevated cancer antigen 125 tumour marker (CA 125).
Mirae Park +3 more
openaire +2 more sources
We present two unusual presentations of extrapulmonary tuberculosis (EPTB) and more specifically intra-abdominal tuberculosis (TB). These cases were initially suspicious for ovarian cancer, presenting with non-specific symptoms, ultrasound-confirmed ascites and elevated cancer antigen 125 tumour marker (CA 125).
Mirae Park +3 more
openaire +2 more sources
2012
?????? ?????????????????????????? ???? 125 ?????? ???????????????????????????????? ?????????????? ?????????????? ?????????????? ?????????? ?????????????? (????) ???????????? ???????????????? ???????????????? ???????????????????????????????????? ???????????? ?????????? ?????????????? ?? ?????????????????? ?????????? ?????????????? ?????????? ????????????
J. A. M. van Balen +7 more
openaire +3 more sources
?????? ?????????????????????????? ???? 125 ?????? ???????????????????????????????? ?????????????? ?????????????? ?????????????? ?????????? ?????????????? (????) ???????????? ???????????????? ???????????????? ???????????????????????????????????? ???????????? ?????????? ?????????????? ?? ?????????????????? ?????????? ?????????????? ?????????? ????????????
J. A. M. van Balen +7 more
openaire +3 more sources
CA 125 in gynecologic practice
American Journal of Obstetrics and Gynecology, 1986Serum CA 125 levels were determined in 64 women with benign ovarian lesions, 92 women with uterine fundal lesions, and six patients who had negative second-look laparotomy for epithelial ovarian carcinoma. Of those with benign lesions, 13 of 31 patients with endometriosis had levels greater than 35 U/ml.
G D, Malkasian +4 more
openaire +2 more sources
CA-125 levels in endometriosis
Fertility and Sterility, 1986CA-125 is a cellular antigen detected in many patients with ovarian cancer, but it has also been detected in patients with endometriosis. Preoperative CA-125 levels were drawn from 113 patients before they underwent laparoscopy. Patients were categorized into diagnostic groups on the basis of pathologic findings. CA-125 levels in patients with evidence
P E, Patton +3 more
openaire +2 more sources
CA-125 in gynecological malignancies
European Journal of Cancer and Clinical Oncology, 1987CA-125 is an antigenic determinant that can be demonstrated in the majority of epithelial ovarian carcinomas. It can be measured in the serum with a radioimmunoassay by means of a monoclonal antibody. The tumor marker has a low specificity but high sensitivity for ovarian cancer, especially for serous cystadenocarcinoma.
W, Meier +4 more
openaire +2 more sources
CA 125 in the management of endometriosis
European Journal of Obstetrics & Gynecology and Reproductive Biology, 1993CA 125 is expressed by eutopic and ectopic endometrium. In women with advanced endometriosis, plasma concentrations are increased towards the end of the luteal phase and during menstruation but not during the follicular and early luteal phases. In women without endometriosis, such cyclic changes of CA 125 in plasma are not observed.
P R, Koninckx +3 more
openaire +2 more sources

